YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD.

Highlights Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

Equities

002675

CNE100001DP5

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-07-04 pm EDT			5-day change	1st Jan Change
12.05 ^CNY	+3.43%		-1.71%	-34.26%

May. 27	Dongcheng Biochemicals' Unit Gets Nod to Trial Pancreatic Cancer Drug	MT
May. 20	Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Approves the Cash Dividend for the Year 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Dongcheng Biochemicals' Unit Gets Nod to Trial Pancreatic Cancer Drug	May. 27	MT
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Approves the Cash Dividend for the Year 2023	May. 20	CI
Dongcheng Biochemicals' Unit Gets Nod to Trial Tumor Drug	Apr. 29	MT
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 26	CI
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
Dongcheng Biochemicals' Unit Gets Nod to Trial Tumor Drug in Singapore	Apr. 11	MT
Dongcheng Pharmaceutical Gets Nod to Trial Tumor Drug in China	Dec. 05	MT
Yantai Dongcheng Pharmaceutical's Unit Ties Up With Chinese Physics Institute for Electron Accelerator Development	Nov. 23	MT
Dongcheng Pharma Forms Medical Isotopes JV With Germany’s Eckert & Ziegler	Nov. 15	MT
Dongcheng Biochemicals Unit Gets Nod to Trial Prostate Cancer Drug in Singapore	Nov. 10	MT
Dongcheng Biochemicals' Unit Gets Nod to Market Dalteparin Sodium Injection	Nov. 01	MT
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Dongcheng Biochemicals Receives Good Manufacturing Practice Certificate from Germany	23-10-18	MT
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-23	CI
Yantai Dongcheng Pharma Registers Raw Material For Deep Vein Thrombosis Drug	23-08-01	MT
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date of 10 July 2023	23-07-03	CI
Dongcheng Pharma Unit Gets Production License for Two Production Centers	23-06-27	MT
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Approves Cash Dividend for 2022	23-05-22	CI
Dongcheng Pharma's Unit Passes GMP Inspection	23-05-09	MT
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Proposes Final Cash Dividend for the Year 2022	23-05-04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

Equities

002675

CNE100001DP5

Highlights

Filters